Loading patent…
AssigneeBayer HealthCare LLC
InventorsSusanne Zuleger, Peter Serno, Helmut Haning, Kerstin Pauli, Roland Heinig
Estimating the term…
The present invention relates to novel pharmaceutical dosage forms with controlled release of active ingredient which comprise the PDE 5 inhibitor vardenafil and/or pharmaceutically acceptable salts, hydrates, solvates and/or polymorphic forms thereof as active ingredient, and to the production thereof. The invention further relates to the use of these novel pharmaceutical dosage forms as medicaments, and to their use for producing medicaments for the treatment and/or prevention of disorders in humans and animals.
Pharmaceutical dosage form with controlled release of active ingredient which comprise the PDE 5 inhibitor vardenafil and/or pharmaceutically acceptable salts and/or hydrates and/or solvates thereof as active ingredient, and which has an average release rate of 5 between 80% in 2 hours and 80% in 24 hours.
Dependencies are inferred from the claim text.